Durvalumab Market - Global Outlook and Forecast 2023-2028

Report ID: 1369883 | Published Date: Jan 2025 | No. of Page: 77 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Durvalumab Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Durvalumab Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Durvalumab Overall Market Size
    2.1 Global Durvalumab Market Size: 2021 VS 2028
    2.2 Global Durvalumab Revenue, Prospects & Forecasts: 2017-2028
    2.3 Global Durvalumab Sales: 2017-2028
3 Company Landscape
    3.1 Top Durvalumab Players in Global Market
    3.2 Top Global Durvalumab Companies Ranked by Revenue
    3.3 Global Durvalumab Revenue by Companies
    3.4 Global Durvalumab Sales by Companies
    3.5 Global Durvalumab Price by Manufacturer (2017-2022)
    3.6 Top 3 and Top 5 Durvalumab Companies in Global Market, by Revenue in 2021
    3.7 Global Manufacturers Durvalumab Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Durvalumab Players in Global Market
        3.8.1 List of Global Tier 1 Durvalumab Companies
        3.8.2 List of Global Tier 2 and Tier 3 Durvalumab Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Durvalumab Market Size Markets, 2021 & 2028
        4.1.2 2.4mL Injection
        4.1.3 10mL Injection
    4.2 By Type - Global Durvalumab Revenue & Forecasts
        4.2.1 By Type - Global Durvalumab Revenue, 2017-2022
        4.2.2 By Type - Global Durvalumab Revenue, 2023-2028
        4.2.3 By Type - Global Durvalumab Revenue Market Share, 2017-2028
    4.3 By Type - Global Durvalumab Sales & Forecasts
        4.3.1 By Type - Global Durvalumab Sales, 2017-2022
        4.3.2 By Type - Global Durvalumab Sales, 2023-2028
        4.3.3 By Type - Global Durvalumab Sales Market Share, 2017-2028
    4.4 By Type - Global Durvalumab Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
    5.1 Overview
        5.1.1 By Application - Global Durvalumab Market Size, 2021 & 2028
        5.1.2 Locally Advanced Urothelial Carcinoma
        5.1.3 Metastatic Urothelial Carcinoma
        5.1.4 Other
    5.2 By Application - Global Durvalumab Revenue & Forecasts
        5.2.1 By Application - Global Durvalumab Revenue, 2017-2022
        5.2.2 By Application - Global Durvalumab Revenue, 2023-2028
        5.2.3 By Application - Global Durvalumab Revenue Market Share, 2017-2028
    5.3 By Application - Global Durvalumab Sales & Forecasts
        5.3.1 By Application - Global Durvalumab Sales, 2017-2022
        5.3.2 By Application - Global Durvalumab Sales, 2023-2028
        5.3.3 By Application - Global Durvalumab Sales Market Share, 2017-2028
    5.4 By Application - Global Durvalumab Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
    6.1 By Region - Global Durvalumab Market Size, 2021 & 2028
    6.2 By Region - Global Durvalumab Revenue & Forecasts
        6.2.1 By Region - Global Durvalumab Revenue, 2017-2022
        6.2.2 By Region - Global Durvalumab Revenue, 2023-2028
        6.2.3 By Region - Global Durvalumab Revenue Market Share, 2017-2028
    6.3 By Region - Global Durvalumab Sales & Forecasts
        6.3.1 By Region - Global Durvalumab Sales, 2017-2022
        6.3.2 By Region - Global Durvalumab Sales, 2023-2028
        6.3.3 By Region - Global Durvalumab Sales Market Share, 2017-2028
    6.4 North America
        6.4.1 By Country - North America Durvalumab Revenue, 2017-2028
        6.4.2 By Country - North America Durvalumab Sales, 2017-2028
        6.4.3 US Durvalumab Market Size, 2017-2028
        6.4.4 Canada Durvalumab Market Size, 2017-2028
        6.4.5 Mexico Durvalumab Market Size, 2017-2028
    6.5 Europe
        6.5.1 By Country - Europe Durvalumab Revenue, 2017-2028
        6.5.2 By Country - Europe Durvalumab Sales, 2017-2028
        6.5.3 Germany Durvalumab Market Size, 2017-2028
        6.5.4 France Durvalumab Market Size, 2017-2028
        6.5.5 U.K. Durvalumab Market Size, 2017-2028
        6.5.6 Italy Durvalumab Market Size, 2017-2028
        6.5.7 Russia Durvalumab Market Size, 2017-2028
        6.5.8 Nordic Countries Durvalumab Market Size, 2017-2028
        6.5.9 Benelux Durvalumab Market Size, 2017-2028
    6.6 Asia
        6.6.1 By Region - Asia Durvalumab Revenue, 2017-2028
        6.6.2 By Region - Asia Durvalumab Sales, 2017-2028
        6.6.3 China Durvalumab Market Size, 2017-2028
        6.6.4 Japan Durvalumab Market Size, 2017-2028
        6.6.5 South Korea Durvalumab Market Size, 2017-2028
        6.6.6 Southeast Asia Durvalumab Market Size, 2017-2028
        6.6.7 India Durvalumab Market Size, 2017-2028
    6.7 South America
        6.7.1 By Country - South America Durvalumab Revenue, 2017-2028
        6.7.2 By Country - South America Durvalumab Sales, 2017-2028
        6.7.3 Brazil Durvalumab Market Size, 2017-2028
        6.7.4 Argentina Durvalumab Market Size, 2017-2028
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Durvalumab Revenue, 2017-2028
        6.8.2 By Country - Middle East & Africa Durvalumab Sales, 2017-2028
        6.8.3 Turkey Durvalumab Market Size, 2017-2028
        6.8.4 Israel Durvalumab Market Size, 2017-2028
        6.8.5 Saudi Arabia Durvalumab Market Size, 2017-2028
        6.8.6 UAE Durvalumab Market Size, 2017-2028
7 Manufacturers & Brands Profiles
    7.1 Medimmune (AstraZeneca)
        7.1.1 Medimmune (AstraZeneca) Corporate Summary
        7.1.2 Medimmune (AstraZeneca) Business Overview
        7.1.3 Medimmune (AstraZeneca) Durvalumab Major Product Offerings
        7.1.4 Medimmune (AstraZeneca) Durvalumab Sales and Revenue in Global (2017-2022)
        7.1.5 Medimmune (AstraZeneca) Key News
8 Global Durvalumab Production Capacity, Analysis
    8.1 Global Durvalumab Production Capacity, 2017-2028
    8.2 Durvalumab Production Capacity of Key Manufacturers in Global Market
    8.3 Global Durvalumab Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Durvalumab Supply Chain Analysis
    10.1 Durvalumab Industry Value Chain
    10.2 Durvalumab Upstream Market
    10.3 Durvalumab Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Durvalumab Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

List of Tables
    Table 1. Key Players of Durvalumab in Global Market
    Table 2. Top Durvalumab Players in Global Market, Ranking by Revenue (2021)
    Table 3. Global Durvalumab Revenue by Companies, (US$, Mn), 2017-2022
    Table 4. Global Durvalumab Revenue Share by Companies, 2017-2022
    Table 5. Global Durvalumab Sales by Companies, (K Pcs), 2017-2022
    Table 6. Global Durvalumab Sales Share by Companies, 2017-2022
    Table 7. Key Manufacturers Durvalumab Price (2017-2022) & (USD/Pcs)
    Table 8. Global Manufacturers Durvalumab Product Type
    Table 9. List of Global Tier 1 Durvalumab Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Durvalumab Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Durvalumab Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Global Durvalumab Revenue (US$, Mn), 2017-2022
    Table 13. By Type - Global Durvalumab Revenue (US$, Mn), 2023-2028
    Table 14. By Type - Global Durvalumab Sales (K Pcs), 2017-2022
    Table 15. By Type - Global Durvalumab Sales (K Pcs), 2023-2028
    Table 16. By Application – Global Durvalumab Revenue, (US$, Mn), 2021 & 2028
    Table 17. By Application - Global Durvalumab Revenue (US$, Mn), 2017-2022
    Table 18. By Application - Global Durvalumab Revenue (US$, Mn), 2023-2028
    Table 19. By Application - Global Durvalumab Sales (K Pcs), 2017-2022
    Table 20. By Application - Global Durvalumab Sales (K Pcs), 2023-2028
    Table 21. By Region – Global Durvalumab Revenue, (US$, Mn), 2021 VS 2028
    Table 22. By Region - Global Durvalumab Revenue (US$, Mn), 2017-2022
    Table 23. By Region - Global Durvalumab Revenue (US$, Mn), 2023-2028
    Table 24. By Region - Global Durvalumab Sales (K Pcs), 2017-2022
    Table 25. By Region - Global Durvalumab Sales (K Pcs), 2023-2028
    Table 26. By Country - North America Durvalumab Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - North America Durvalumab Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - North America Durvalumab Sales, (K Pcs), 2017-2022
    Table 29. By Country - North America Durvalumab Sales, (K Pcs), 2023-2028
    Table 30. By Country - Europe Durvalumab Revenue, (US$, Mn), 2017-2022
    Table 31. By Country - Europe Durvalumab Revenue, (US$, Mn), 2023-2028
    Table 32. By Country - Europe Durvalumab Sales, (K Pcs), 2017-2022
    Table 33. By Country - Europe Durvalumab Sales, (K Pcs), 2023-2028
    Table 34. By Region - Asia Durvalumab Revenue, (US$, Mn), 2017-2022
    Table 35. By Region - Asia Durvalumab Revenue, (US$, Mn), 2023-2028
    Table 36. By Region - Asia Durvalumab Sales, (K Pcs), 2017-2022
    Table 37. By Region - Asia Durvalumab Sales, (K Pcs), 2023-2028
    Table 38. By Country - South America Durvalumab Revenue, (US$, Mn), 2017-2022
    Table 39. By Country - South America Durvalumab Revenue, (US$, Mn), 2023-2028
    Table 40. By Country - South America Durvalumab Sales, (K Pcs), 2017-2022
    Table 41. By Country - South America Durvalumab Sales, (K Pcs), 2023-2028
    Table 42. By Country - Middle East & Africa Durvalumab Revenue, (US$, Mn), 2017-2022
    Table 43. By Country - Middle East & Africa Durvalumab Revenue, (US$, Mn), 2023-2028
    Table 44. By Country - Middle East & Africa Durvalumab Sales, (K Pcs), 2017-2022
    Table 45. By Country - Middle East & Africa Durvalumab Sales, (K Pcs), 2023-2028
    Table 46. Medimmune (AstraZeneca) Corporate Summary
    Table 47. Medimmune (AstraZeneca) Durvalumab Product Offerings
    Table 48. Medimmune (AstraZeneca) Durvalumab Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
    Table 49. Durvalumab Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2020-2022 (K Pcs)
    Table 50. Global Durvalumab Capacity Market Share of Key Manufacturers, 2020-2022
    Table 51. Global Durvalumab Production by Region, 2017-2022 (K Pcs)
    Table 52. Global Durvalumab Production by Region, 2023-2028 (K Pcs)
    Table 53. Durvalumab Market Opportunities & Trends in Global Market
    Table 54. Durvalumab Market Drivers in Global Market
    Table 55. Durvalumab Market Restraints in Global Market
    Table 56. Durvalumab Raw Materials
    Table 57. Durvalumab Raw Materials Suppliers in Global Market
    Table 58. Typical Durvalumab Downstream
    Table 59. Durvalumab Downstream Clients in Global Market
    Table 60. Durvalumab Distributors and Sales Agents in Global Market
List of Figures
    Figure 1. Durvalumab Segment by Type
    Figure 2. Durvalumab Segment by Application
    Figure 3. Global Durvalumab Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Durvalumab Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Durvalumab Revenue, 2017-2028 (US$, Mn)
    Figure 7. Durvalumab Sales in Global Market: 2017-2028 (K Pcs)
    Figure 8. The Top 3 and 5 Players Market Share by Durvalumab Revenue in 2021
    Figure 9. By Type - Global Durvalumab Sales Market Share, 2017-2028
    Figure 10. By Type - Global Durvalumab Revenue Market Share, 2017-2028
    Figure 11. By Type - Global Durvalumab Price (USD/Pcs), 2017-2028
    Figure 12. By Application - Global Durvalumab Sales Market Share, 2017-2028
    Figure 13. By Application - Global Durvalumab Revenue Market Share, 2017-2028
    Figure 14. By Application - Global Durvalumab Price (USD/Pcs), 2017-2028
    Figure 15. By Region - Global Durvalumab Sales Market Share, 2017-2028
    Figure 16. By Region - Global Durvalumab Revenue Market Share, 2017-2028
    Figure 17. By Country - North America Durvalumab Revenue Market Share, 2017-2028
    Figure 18. By Country - North America Durvalumab Sales Market Share, 2017-2028
    Figure 19. US Durvalumab Revenue, (US$, Mn), 2017-2028
    Figure 20. Canada Durvalumab Revenue, (US$, Mn), 2017-2028
    Figure 21. Mexico Durvalumab Revenue, (US$, Mn), 2017-2028
    Figure 22. By Country - Europe Durvalumab Revenue Market Share, 2017-2028
    Figure 23. By Country - Europe Durvalumab Sales Market Share, 2017-2028
    Figure 24. Germany Durvalumab Revenue, (US$, Mn), 2017-2028
    Figure 25. France Durvalumab Revenue, (US$, Mn), 2017-2028
    Figure 26. U.K. Durvalumab Revenue, (US$, Mn), 2017-2028
    Figure 27. Italy Durvalumab Revenue, (US$, Mn), 2017-2028
    Figure 28. Russia Durvalumab Revenue, (US$, Mn), 2017-2028
    Figure 29. Nordic Countries Durvalumab Revenue, (US$, Mn), 2017-2028
    Figure 30. Benelux Durvalumab Revenue, (US$, Mn), 2017-2028
    Figure 31. By Region - Asia Durvalumab Revenue Market Share, 2017-2028
    Figure 32. By Region - Asia Durvalumab Sales Market Share, 2017-2028
    Figure 33. China Durvalumab Revenue, (US$, Mn), 2017-2028
    Figure 34. Japan Durvalumab Revenue, (US$, Mn), 2017-2028
    Figure 35. South Korea Durvalumab Revenue, (US$, Mn), 2017-2028
    Figure 36. Southeast Asia Durvalumab Revenue, (US$, Mn), 2017-2028
    Figure 37. India Durvalumab Revenue, (US$, Mn), 2017-2028
    Figure 38. By Country - South America Durvalumab Revenue Market Share, 2017-2028
    Figure 39. By Country - South America Durvalumab Sales Market Share, 2017-2028
    Figure 40. Brazil Durvalumab Revenue, (US$, Mn), 2017-2028
    Figure 41. Argentina Durvalumab Revenue, (US$, Mn), 2017-2028
    Figure 42. By Country - Middle East & Africa Durvalumab Revenue Market Share, 2017-2028
    Figure 43. By Country - Middle East & Africa Durvalumab Sales Market Share, 2017-2028
    Figure 44. Turkey Durvalumab Revenue, (US$, Mn), 2017-2028
    Figure 45. Israel Durvalumab Revenue, (US$, Mn), 2017-2028
    Figure 46. Saudi Arabia Durvalumab Revenue, (US$, Mn), 2017-2028
    Figure 47. UAE Durvalumab Revenue, (US$, Mn), 2017-2028
    Figure 48. Global Durvalumab Production Capacity (K Pcs), 2017-2028
    Figure 49. The Percentage of Production Durvalumab by Region, 2021 VS 2028
    Figure 50. Durvalumab Industry Value Chain
    Figure 51. Marketing Channels
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Durvalumab Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Durvalumab Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Durvalumab Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Pembrolizumab Market

This report contains market size and forecasts of Pembrolizumab in global, including the followin ... Read More

Atezolizumab Market

This report contains market size and forecasts of Atezolizumab in global, including the following ... Read More

Avelumab Market

This report contains market size and forecasts of Avelumab in global, including the following mar ... Read More